Eero Mattila
Helsinki, 00029, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial.
Journal: World journal of gastroenterology
Published: December 27, 2022
Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements.
Journal: Emerging infectious diseases
Published: July 21, 2021
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: August 28, 2020
Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: July 14, 2020
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.
Journal: United European gastroenterology journal
Published: July 02, 2020
Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent Clostridioides difficile infection in clinical practice.
Journal: Infectious diseases (London, England)
Published: June 10, 2020
Cultivation and Genomics Prove Long-Term Colonization of Donor's Bifidobacteria in Recurrent Clostridioides difficile Patients Treated With Fecal Microbiota Transplantation.
Journal: Frontiers in microbiology
Published: March 23, 2020
Treatment of Clostridioides (Clostridium) difficile infection.
Journal: Annals of medicine
Published: December 06, 2019
Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Journal: Alimentary pharmacology & therapeutics
Published: November 20, 2019
Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in Mice.
Journal: Frontiers in microbiology
Published: July 05, 2019
Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: April 23, 2019
Last Updated: 09/26/2026